Management of Elevated Troponin I with Ventricular Premature Beats

Initial Assessment

The American Heart Association recommends obtaining a 12-lead ECG immediately to assess for ischemic changes, conduction abnormalities, and characterize the VPBs 1, 2
The American College of Cardiology suggests measuring cardiac-specific troponin (I or T) at presentation and 3-6 hours after symptom onset to identify rising/falling patterns indicative of acute myocardial injury 1, 2
Consider additional troponin measurements beyond 6 hours in patients with normal initial values if clinical suspicion remains high, as recommended by the American Heart Association 1
Perform echocardiography to assess for structural heart disease, wall motion abnormalities, and ventricular function, as suggested by the European Society of Cardiology 3, 2
Evaluate for other cardiac biomarkers including BNP/NT-proBNP to assess for heart failure, as recommended by the European Society of Cardiology 4

Acute coronary syndrome (unstable angina, NSTEMI, STEMI) is a possible diagnosis, according to the European Society of Cardiology 1, 5
Pulmonary embolism with right ventricular strain is another possible diagnosis, as suggested by the European Society of Cardiology 6, 7

Rising/falling troponin pattern with values above the 99th percentile suggests acute myocardial injury, according to the American Heart Association 1, 2
Elevated troponin in the setting of VPBs without evidence of ACS still indicates increased mortality risk and requires thorough evaluation, as recommended by the European Society of Cardiology 5

Manage patients with rising troponin and ischemic ECG changes as NSTEMI according to ACS guidelines, as recommended by the American Heart Association 1
Consider cardiac catheterization based on risk stratification, as suggested by the American Heart Association 1
Initiate antiplatelet therapy, anticoagulation, and other guideline-directed medical therapy, as recommended by the American Heart Association 1

Even mildly elevated troponin levels carry prognostic significance and should not be dismissed as clinically insignificant, according to the European Society of Cardiology 2
Serial troponin measurements are essential to distinguish acute from chronic myocardial injury, as recommended by the American Heart Association 1, 2
Patients with immune checkpoint inhibitor therapy require special attention as elevated troponin may indicate immune-related myocarditis, which requires prompt corticosteroid therapy, as suggested by the American Society of Clinical Oncology 3